Charles Lu
Impact in
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Genetics top 0.1%
- Glioma Diagnosis and Treatment
Papers in
-
- Cancer Genomics and Diagnostics 25
-
- Epigenetics and DNA Methylation 8
- CRISPR and Genetic Engineering 6
- RNA modifications and cancer 5
- Co-authors
- Mingchao Xie (3 shared papers)Michael D. McLellan (3 shared papers)Michael C. Wendl (3 shared papers)Li Ding (3 shared papers)Kai Ye (2 shared papers)Beifang Niu (2 shared papers)Qunyuan Zhang (2 shared papers)Christopher A. Miller (4 shared papers)
- Journals
- Nature (10 papers)Nature Communications (7 papers)Nature Genetics (6 papers)PLoS ONE (5 papers)Cell Reports (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Charles Lu
77 papers receiving 22.0k citations
Charles Lu's Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 5.9k
- Genetics 3.8k
- Hematology 3.6k
- Oncology 4.3k
- Molecular Biology 10.6k
Countries citing papers authored by Charles Lu
This map shows the geographic impact of Charles Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Lu more than expected).
Fields of papers citing papers by Charles Lu
This network shows the impact of papers produced by Charles Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Lu. The network helps show where Charles Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutational landscape and significance across 12 major cancer types Hit paper breakdown → | 2013 | 3530 |
| 2 | Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing Hit paper breakdown → | 2012 | 1645 |
| 3 | Age-related mutations associated with clonal hematopoietic expansion and malignancies Hit paper breakdown → | 2014 | 1511 |
| 4 | Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas Hit paper breakdown → | 2012 | 1359 |
| 5 | The Origin and Evolution of Mutations in Acute Myeloid Leukemia Hit paper breakdown → | 2012 | 1285 |
| 6 | Integrated genomic and molecular characterization of cervical cancer Hit paper breakdown → | 2017 | 1221 |
| 7 | Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus Hit paper breakdown → | 2005 | 1177 |
| 8 | The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma Hit paper breakdown → | 2014 | 856 |
| 9 | Whole-genome analysis informs breast cancer response to aromatase inhibition Hit paper breakdown → | 2012 | 840 |
| 10 | Novel mutations target distinct subgroups of medulloblastoma Hit paper breakdown → | 2012 | 711 |
| 11 | Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas Hit paper breakdown → | 2013 | 679 |
| 12 | MSIsensor: microsatellite instability detection using paired tumor-normal sequence data Hit paper breakdown → | 2013 | 647 |
| 13 | Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma Hit paper breakdown → | 2014 | 598 |
| 14 | The genomic landscape of hypodiploid acute lymphoblastic leukemia Hit paper breakdown → | 2013 | 556 |
| 15 | Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts Hit paper breakdown → | 2013 | 527 |
| 16 | C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma Hit paper breakdown → | 2014 | 522 |
| 17 | 2012 | 411 | |
| 18 | 2015 | 400 | |
| 19 | The Integrated Genomic Landscape of Thymic Epithelial Tumors Hit paper breakdown → | 2018 | 286 |
| 20 | 2005 | 275 |
About Charles Lu
Charles Lu is a scholar working on Cancer Research, Molecular Biology, Hematology, Oncology and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 22.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (25 papers), Lung Cancer Treatments and Mutations (9 papers), Epigenetics and DNA Methylation (8 papers), Genetic factors in colorectal cancer (6 papers), CRISPR and Genetic Engineering (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (6 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (5.9k citations), Genetics (3.8k citations), Hematology (3.6k citations), Oncology (4.3k citations) and Molecular Biology (10.6k citations). Charles Lu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Mingchao Xie, Michael D. McLellan, Michael C. Wendl, Li Ding, Kai Ye, Beifang Niu, Qunyuan Zhang, Christopher A. Miller, Richard K. Wilson and Timothy James Ley. Their work appears in journals such as Nature, Nature Communications, Nature Genetics, PLoS ONE and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.